These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18470602)

  • 21. Azygos vein lead implantation: a novel adjunctive technique for implantable cardioverter defibrillator placement.
    Cesario D; Bhargava M; Valderrábano M; Fonarow GC; Wilkoff B; Shivkumar K
    J Cardiovasc Electrophysiol; 2004 Jul; 15(7):780-3. PubMed ID: 15250862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
    Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G
    Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transvenous biventricular defibrillation.
    Meisel E; Butter C; Philippon F; Higgins S; Strickberger SA; Smith J; Hahn S; Michel U; Schubert B; Pfeiffer D
    Am J Cardiol; 2000 Nov; 86(9A):76K-85K. PubMed ID: 11084104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal method to achieve consistently low defibrillation energy requirements.
    Winter J; Zimmermann N; Lidolt H; Dees H; Perings C; Vester EG; Poll L; Schipke JD; Contzen K; Gams E
    Am J Cardiol; 2000 Nov; 86(9A):71K-75K. PubMed ID: 11084103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical predictors of atrial defibrillation thresholds with a dual-coil, active pectoral lead system.
    Rashba EJ; Shorofsky SR; Brown T; Peters RW; Gold MR
    Heart Rhythm; 2005 Jan; 2(1):49-54. PubMed ID: 15851265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of shock polarity reversal on defibrillation threshold in an implantable cardioverter-defibrillator.
    Zienciuk A; Lubiński A; Królak T; Lewicka-Nowak E; Kempa M; Pazdyga A; Raczak G
    Kardiol Pol; 2007 May; 65(5):495-500; discussion 501-2. PubMed ID: 17577846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel intravascular defibrillator: defibrillation thresholds of intravascular cardioverter-defibrillator compared to conventional implantable cardioverter-defibrillator in a canine model.
    Sanders WE; Richey MW; Malkin RA; Masson SC; Ransbury TJ; Urtz MW; Ideker RE
    Heart Rhythm; 2011 Feb; 8(2):288-92. PubMed ID: 21034853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of automated subcutaneous defibrillator screening between different pacing sites in cardiac pacing device carriers.
    Molina-Lerma M; Cabrera-Borrego E; Rivera-Lopez R; Sánchez-Millán P; Peña Mellado J; Arriaga Jiménez A; Álvarez M
    Europace; 2023 Dec; 25(12):. PubMed ID: 38019960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of shock polarity on biphasic defibrillation thresholds using an active pectoral lead system.
    Olsovsky MR; Shorofsky SR; Gold MR
    J Cardiovasc Electrophysiol; 1998 Apr; 9(4):350-4. PubMed ID: 9581951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of shock polarity on defibrillation thresholds with a hybrid patch-coil lead system.
    Rashba EJ; Shorofsky SR; Peters RW; Gold MR
    J Interv Card Electrophysiol; 2003 Dec; 9(3):391-6. PubMed ID: 14618062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience.
    Essandoh MK; Portillo JG; Weiss R; Otey AJ; Zuleta-Alarcon AN; Humeidan ML; Torres JL; Flores AS; Castellon-Larios K; Abdel-Rasoul M; Andritsos MJ; Perez WJ; Stein EJ; Turner KR; Dimitrova GT; Awad H; Bhandary SP; Tripathi RS; Joseph NC; Hummel JD; Augostini RS; Kalbfleisch SJ; Tyler JD; Houmsse M; Daoud EG
    J Clin Anesth; 2016 Jun; 31():53-9. PubMed ID: 27185678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing: 2-year follow-up.
    Bianchi S; Ricci RP; Biscione F; Sgreccia F; Di Belardino N; Rossi P; Giuli S; Grammatico A; De Santo T; Santi E; Merico M; Piccirillo G; Azzolini P; Santini M; Puglisi A
    Pacing Clin Electrophysiol; 2009 May; 32(5):573-8. PubMed ID: 19422577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of an active abdominal pulse generator on defibrillation thresholds with a dual-coil, transvenous ICD lead system.
    Rashba EJ; Farasat M; Kirk MM; Shorofsky SR; Peters RW; Gold MR
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):617-20. PubMed ID: 16836709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of Regular Defibrillation Threshold Testing After Extracardiac Implantable Cardioverter Defibrillator Placement in Small Children During Mid-Term Follow-Up.
    Kriebel T; Müller MJ; Ruschewski W; Krause U; Paul T; Schneider H
    JACC Clin Electrophysiol; 2018 Jul; 4(7):936-943. PubMed ID: 30025695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Tuned" defibrillation waveforms outperform 50/50% tilt defibrillation waveforms: a randomized multi-center study.
    Natarajan S; Henthorn R; Burroughs J; Esberg D; Zweibel S; Ross T; Kroll M; Gianola D; Oza A
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S139-42. PubMed ID: 17302691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High dispersion of ventricular repolarization after an implantable defibrillator shock predicts induction of ventricular fibrillation as well as unsuccessful defibrillation.
    Moubarak JB; Karasik PE; Fletcher RD; Franz MR
    J Am Coll Cardiol; 2000 Feb; 35(2):422-7. PubMed ID: 10676690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of malpositioned transvenous leads on defibrillation efficacy with and without a subcutaneous array electrode.
    Usui M; Walcott GP; KenKnight BH; Walker RG; Rollins DL; Smith WM; Ideker RE
    Pacing Clin Electrophysiol; 1995 Nov; 18(11):2008-16. PubMed ID: 8552514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of a high defibrillation threshold test during routine ICD implantation.
    Al-Atia B; Vandenberk B; Vörös G; Garweg C; Ector J; Willems R
    Acta Cardiol; 2018 Jun; 73(3):267-273. PubMed ID: 28885097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-energy endocardial defibrillation using an axillary or a pectoral thoracic electrode location.
    Saksena S; DeGroot P; Krol RB; Raju R; Mathew P; Mehra R
    Circulation; 1993 Dec; 88(6):2655-60. PubMed ID: 8252676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated defibrillation threshold when right-sided venous access is used for nonthoracotomy implantable defibrillator lead implantation. The Endotak Investigators.
    Epstein AE; Kay GN; Plumb VJ; Voshage-Stahl L; Hull ML
    J Cardiovasc Electrophysiol; 1995 Nov; 6(11):979-86. PubMed ID: 8589875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.